Pharmaceutical pricing in a regulated market

Review of Economics and Statistics

Volumn 85, Issue 2, 2003, Pages 298-306

  Ekelund, Mats ^a   Persson, Björn ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038015669     PISSN: 00346535     EISSN: None     Source Type: Journal    
DOI: 10.1162/003465303765299828     Document Type: Review

References (17)

1. Abbott III, T. A., "Price Regulation in the Pharmaceutical Industry: Prescription or Placebo?" Journal of Health Economics 14 (1995), 551-565.
2. Besley, T., and M. Gouveia, "Alternative Systems of Health Care Provision," Economic Policy 9:19 (1994), 199-258.
3. Caves, R. E., M. D. Whinston, and M. A. Hurwitz, "Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry," Brookings Papers on Economic Activity: Microeconomics (1991), 3-65.
4. Danzon, P. M., Pharmaceutical Price Regulation: National Policies versus Global Interests (Washington: AEI Press, 1997).
5. Danzon, P. M., and L.-W. Chao, "Cross-National Price Differences for Pharmaceuticals: How Large, and Why?" Journal of Health Economics 19 (2000a), 159-195.
6. _ "Does Regulation Drive out Competition in Pharmaceutical Markets?" Journal of Law and Economics 43:2 (2000b), 311-358.
7. Dean, J., "Pricing of Pioneering Products," Journal of Industrial Economics 17 (1969), 165-179.
8. FASS (Pharmaceutical Specialties in Sweden), (Elanders, Kungsbacka: Läkemedelsinformation AB, 1988-1998).
9. Frank, R. E., and D. S. Salkever, "Generic Entry and the Pricing of Pharmaceuticals," Journal of Economics and Management Strategy 6:1 (1997), 75-90.
10. Grabowsici, H. G., and J. M. Vernon, "Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act," Journal of Law and Economics 35 (1992), 331-350.
11. Lu, Z. J., and W. S. Comanor, "Strategic Pricing of New Pharmaceuticals," Review of Economics and Statistics 80:1 (1998), 108-118.
12. Nilsson, J. L. G., et al., "Användningen av Generiska Läkemedel i Sverige," NEPI report (1998).
13. Reekie, W. D., "Price and Quality Competition in the United States Drug Industry," Journal of Industrial Economics 26 (1978), 223-237.
14. Rosén, A., and B. Beermann, "Rating innovative therapeutic benefits of medicines licensed in Sweden 1987-1997," International Journal of Pharmaceutical Medicine 13 (1999), 123-126.
15. Statistical Yearbook of Sweden (Stockholm: Statistics Sweden, 1999).
16. Swedish Drug Market (SDM), Sales and price statistics compiled by The Swedish Association of the Pharmaceutical Industry (1987-1997).
17. WHO Collaborating Centre for Drug Statistics Methodology, ATC Index with DDD's 1997 (Oslo, 1997).